<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1027-2852</journal-id>
<journal-title><![CDATA[Biotecnología Aplicada]]></journal-title>
<abbrev-journal-title><![CDATA[Biotecnol Apl]]></abbrev-journal-title>
<issn>1027-2852</issn>
<publisher>
<publisher-name><![CDATA[Editorial Elfos Scientiae]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1027-28522010000200013</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[New ways to socialize knowledge about a product: School of advanced studies of Heberprot-P]]></article-title>
<article-title xml:lang="es"><![CDATA[Vías de socialización del conocimiento sobre un producto: Escuela de estudios avanzados del Heberprot-P]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Negrín]]></surname>
<given-names><![CDATA[Sonia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valdés]]></surname>
<given-names><![CDATA[Raúl A]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Días]]></surname>
<given-names><![CDATA[Wilfredo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[Miriela]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Mola]]></surname>
<given-names><![CDATA[Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Centro de Ingeniería Genética y Biotecnología  ]]></institution>
<addr-line><![CDATA[Ciudada de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2010</year>
</pub-date>
<volume>27</volume>
<numero>2</numero>
<fpage>177</fpage>
<lpage>178</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1027-28522010000200013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1027-28522010000200013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1027-28522010000200013&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[ <DIV class="Sect"   >        <P align="right"   ><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif"><b>FOCUS</b></font></P >       <P align="right"   >&nbsp;</P >   <FONT size="+1" color="#000000">        <P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><B><font size="4">New      ways to socialize knowledge about a product: School of advanced studies of      Heberprot-P</font></b></font></P >       <P   >&nbsp;</P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif"><b><font size="3">V&iacute;as      de socializaci&oacute;n del conocimiento sobre un producto: Escuela de estudios      avanzados del Heberprot-P</font></b></font></P >       <P   >&nbsp;</P >       <P   >&nbsp;</P >   <FONT size="+1">        <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Sonia Negr&iacute;n,      Ra&uacute;l A Vald&eacute;s, Wilfredo D&iacute;as, Miriela Gil, Ernesto L&oacute;pez      Mola</b> </font></P >   <FONT size="+1">        <P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Centro de Ingenier&iacute;a      Gen&eacute;tica y Biotecnolog&iacute;a, CIGB Ave. 31 entre 158 y 190, Cubanac&aacute;n,      Playa, AP 6162, CP 10 600, Ciudad de La Habana, Cuba</font></P >   </font></font></font>    <hr>   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">        ]]></body>
<body><![CDATA[<P   >&nbsp;</P >       <P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> </font></P >   <FONT size="+1">        <P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><font size="3">SCHOOL      PRODUCTS: HEBERPROT-P </font></b></font></P >   <FONT size="+1">        <P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">At present, the biggest      pharmaceutical industries worldwide invest extraordinary sums not only creating      and developing cognitive elements related to obtaining and selling products      (1-3); but also searching for different ways and forms of structuring this      knowledge to guarantee that clients, producers, traders, and salesmen have      a close and deep knowledge about the product basic features, its modes and      mechanisms of action, studies achieved, benefits, adverse effects, marketing      projects, niches and others; to allow incorporating working steps, its use,      as well as improving and influencing in the public perception. </font></P >   <FONT size="+1">        <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In the global pharmaceutical      industry, different specialists have been created on behalf of the enterprises      to work with specific products to ensure its knowledge and marketing. According      to their different names, they achieve particular interest and specific points      about the developing or to be developed product in the centers. They have      different names depending on the country or region, for example among the      most known are the following: </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&bull; Medical representative      or Sales representative and/or medical visitor (Venezuela) </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&bull; Pharmaceutical      sales representative and/or medical visitor(Argentina and Uruguay) </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&bull; Sanitary technical      reporter (Europe) </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&bull; <I>Medical      Repre </I>(Mexico) </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&bull; <I>Medical      Scout </I>(USA) (4, 5) </font></P >       ]]></body>
<body><![CDATA[<P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">According to the      Cuban biotechnological product, Heberprot-P taken as the object of this approach,      there is, as in every product of human creativity, an enormous wealth of knowledge      particularly expressed in the obtained medication and its application, in      which the organizational intelligence, intellectual abilities and all processes      are involved intangible for its development; which represents knowledge, the      result of joining the financial and intellectual resources of the Cuban biotechnology.      </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">This integration      aims at producing knowledge from the integral society needs which involve      the products that cover the unmet human needs, as in the case of Heberprot-P      (6), a product obtained in the center for Genetic Engineering and Biotechnology      that contains the recombinant human epithermal growth factor which action      consists in stimulating the proliferation of fibroblasts, keratinocytes and      endothelial cells of blood vessels in ulcers formed in the diabetic foot because      of the destruction of cell death and tissue necrosis. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Heberprot-P is aimed      at healing deep and complex ulcers so stimulation is an essential el ement,      as well as understanding mechanisms that enable this product to stimulate      tissue granu lation and epithelization accelerated in these ulcers. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Its application by      parenteral administration through intra and perilesional routes constitutes      a basis for its use; as well as its therapeutic properties and niche indications      which are unique in the world; consequently makes this product an item of      great interest and need for cognitive interest and promotion and marketing      of their properties and prospects not only for medical and paramedic staff      but also traders, merchants, students and the whole population. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The cognitive interest      has been identified in five main ways: the medical and paramedical personnel,      the medical students and other related specialties, product promoters, the      public perception in the population, and the school about the product. The      structure of a scientific school about a product is in itself a way of particular      importance and relevance, which is based on strengths and novelty of the product,      for example the School of Advanced Studies about Heberprot P. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Therefore, different      programs become established based on training, reassess, marketing, promotion      and spread out to enable in a flexible way, the cognitive objectives about      a product and its use. Taking this into account, modular teaching is an important      methodology item for structuring knowledge to reinforce modules according      to particular interests of the receivers of knowledge. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">According to the      way related to medical and paramedical staff and students of medicine and      related careers, it is feasible to conduct the socialization of knowledge      through specific cycles of lectures with modular teaching of theoretical and      practical classes, which has become into a repository combining from the most      basic and molecular knowledge of the product to the most commercial ones referred      to advantages and benefits of the it; not only endorsed by a particular company      but also for the scientific and technical knowledge supported by researches,      development and production of the medication based on quality system, its      support in casuistry and the main indicators for its impact on use (8-10).      </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The way of promoters      that can be grouped by technicians and professionals from different specialties,      in such a way to make them multipliers of a product in different scenes, from      the cognitive point of view, match up with the modular teaching adaptation      of objectives which has been worked joining this practical teaching of the      spread out by delivering lectures and the direct link to the treatment of      patients in the most social aspects of it together with the doctor and the      nurse. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The way of public      perception aims at preparing the population to receive a product that directly      affects their health indicators. Thus; it is feasible to use different platforms,      among them, the television. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">If the &ldquo;method      of the near&rdquo; to the receiver is used, our linking items to socialize      knowledge are diabetes, diabetic foot and biotechnology. The design of a deep      and pleasant course combining lectures and all the emerging electronic media      that is, audiovisuals, graphics and videos, allowing from the conceptual point      of view of Biotechnology and identifying diabetes as a serious health problem      for the world&rsquo;s population, to explain the molecular bases of this illness,      its genetic and environmental factors that be identified, incidence of age      structure; adding the development of biotechnology, its link to diabetes and      the new generation products like Heberprot P , its characteristics and projects      for future research on this field. </font></P >       ]]></body>
<body><![CDATA[<P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The way of the School      of Advanced Studies about Heberprot-P provides its feasibility to be done      in 4 times a year, is designed in a modular and face to face instruction,      from 12 to 20 hours. It has a national and international nature in different      languages Spanish, French and English. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The main objectives      are directed about the characteristics of Heberprot-P according to: </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. To teach the personnel      on issues related to Molecular Biology of its active ingredient </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. To discuss the      key features of the product </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. To analyze the      pharmacological and toxicological results of its application. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. To analyze clinical      trials and study of different cases </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Learn the techniques      and principles for implementation the application of Heberprot-P </font></P >       <P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><font size="3">MODULES      OF THE SAS HEBERPROT-P</font></b> </font></P >   <FONT size="+1">        <P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Module 1 </b></font></P >   <FONT size="+1">        <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Diabetes. Characteristics      of this illness. Global Incidence of Diabetes. Heredity and Environment in      Diabetes. The human epidermal growth factor EGF. Discovery of molecular features      FCE FCE. Their uses. Production technologies of recombinant EGF. Characteristics.      </font></P >       ]]></body>
<body><![CDATA[<P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Heberprot-P. Molecular      characteristics of P. Heberprot P Heberprot as biotech product. P. Heberprot      Benefits Formulation and packaging. Presentation. Paradigm shift in the amputation      with the use of P. Heberprot. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Module 2: preclinical      and clinical trials.</b> </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">- Preclinical trials      with P. Heberprot Protocols. Toxicology and pharmacology studies. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">- Clinical trials      with P. Heberprot-P. Protocols of clinical trials. criteria of patient inclusion.      Testing Phase I, II and III. Post-marketing trial. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">- Case studies (analysis).      </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Module 3: Treatment      with Heberprot-P</b> </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Heberprot-P: application      in diabetic patients. Procedures of the treatment. Principles and Techniques      used. Theoretical and practical demonstration about the application of the      product. Analysis and discussion of results of the development of treatments      and applications. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Module 4: Displaying      educational, interactive and informative videos about Heberprot P</b> </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Discuss and view      multimedia, 3D simulation analysis, see video demonstrations of surgical operations      in patients with different stages of evolution of the disease. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The ways to socialize      knowledge about this product allow not only to know it, increase sales and      demands, influence in the research of its development, increase awareness      and culture of the population, but also and mainly draw on knowledge in the      context of the society and make the results of science and technology essential      in raising life&rsquo;s quality of the population, a key objective of the      Cuban biotechnology. </font></P >       ]]></body>
<body><![CDATA[<P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><font size="3">REFERENCES</font></b>      </font></P >       <!-- ref --><P   ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Web del visitador      m&eacute;dico. <a href="http://www.apmcampus.com.ar">http://www.apmcampus.com.ar</a>      Consultada: 16 de agosto 2009. </font></P >   <FONT size="+1">        <!-- ref --><P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. La revista digital      del visitador m&eacute;dico. Disponible en: <a href="http://www.visitadormedico.com">http://www.visitadormedico.com</a>      (consultado: 7 de septiembre de 2009). </font></P >       <!-- ref --><P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. El visitador m&eacute;dico      - Informaci&oacute;n. <a href="http://www.elvisitadormedico.com.ar">http://www.elvisitadormedico.com.ar</a>      (consultado: 24 de septiembre de 2009). </font></P >       <!-- ref --><P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Confederaci&oacute;n      Espa&ntilde;ola de Asociaciones Profesionales de Visitadores M&eacute;dicos.      Disponible en: <a href="http://www.ceatimef.com">http://www.ceatimef.com</a>      (consultado: 4 de julio de 2010). </font></P >       <!-- ref --><P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Obra Social y      Sindicato de Visitadores M&eacute;dicos de la Rep&uacute;blica Argentina.      <a href="http://www.aapmcapital.com.ar">http://www.aapmcapital.com.ar</a>      (consultado: 24 septiembre de 2009). </font></P >       <!-- ref --><P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Herrera L, Negr&iacute;n      S, Vald&eacute;s RA. El Polo Cient&iacute;fico: una red de conocimiento. Nueva      Empresa 2009;6:195-208. </font></P >       <!-- ref --><P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Negr&iacute;n      S, Ayala M, Ra&iacute;ces MR, Cremata JR, Quintana M, P&eacute;rez GL, et      al. Universidad para todos. Curso de introducci&oacute;n a la Biotecnolog&iacute;a.      La Habana, Editorial Juventud Rebelde. La Habana, Cuba, 2003. 32 p.    <br>         <!-- ref --><br>     8. Negr&iacute;n S, Ayala M, Sosa A, Diosdado E, Herrera L, Berovides V, et      al. Universidad para todos. Historia y repercusi&oacute;n de un descubrimiento.      La estructura espacial de la mol&eacute;cula de ADN. La Habana, Editorial      Academia. Cuba, 2003. 32 p.    <br>         <!-- ref --><br>     9. Negr&iacute;n S, Sosa A, Ayala M, Castellanos LR, Padr&oacute;n GR, Fern&aacute;ndez      JR, et al. Universidad para Todos curso: Proyecto Genoma Humano. La Habana,      Editorial Academia. Cuba, 2005. 32 p.    <br>         <!-- ref --><br>     10. Negr&iacute;n S, Sosa A, Ayala M, Fern&aacute;ndez JR, Pujols M, Gonz&aacute;lez      LJ, et al. Universidad para Todos: Biotecnolog&iacute;a y adulto mayor. La      Habana, Editorial Academia. Cuba, 2008. 32 p.    <br>     </font> </P >       <P   > </P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Received in August,      2010.    <br>     </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Accepted      for publication in September, 2010. </font></P >       <P   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Sonia Negr&iacute;n,      Centro de Ingenier&iacute;a Gen&eacute;tica y Biotecnolog&iacute;a, CIGB Ave.      31 entre 158 y 190, Cubanac&aacute;n, Playa, AP 6162, CP 10 600, Ciudad de      La Habana, Cuba E-mail:<a href="mailto:sonia.negrin@cigb.edu.cu">sonia.negrin@cigb.edu.cu</a></font></P >   </font></font></font></font></font></font></font></font></font></DIV >      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<source><![CDATA[Web del visitador médico]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<source><![CDATA[La revista digital del visitador médico]]></source>
<year>7 de</year>
<month> s</month>
<day>ep</day>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<source><![CDATA[El visitador médico: Información]]></source>
<year>24 d</year>
<month>e </month>
<day>se</day>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<source><![CDATA[Confederación Española de Asociaciones Profesionales de Visitadores Médicos]]></source>
<year>4 de</year>
<month> j</month>
<day>ul</day>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<source><![CDATA[Obra Social y Sindicato de Visitadores Médicos de la República Argentina]]></source>
<year>24 s</year>
<month>ep</month>
<day>ti</day>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Negrín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[El Polo Científico: una red de conocimiento]]></article-title>
<source><![CDATA[Nueva Empresa]]></source>
<year>2009</year>
<volume>6</volume>
<page-range>195-208</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Negrín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Raíces]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Cremata]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<source><![CDATA[Universidad para todos: Curso de introducción a la Biotecnología]]></source>
<year>2003</year>
<page-range>32</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Juventud Rebelde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Negrín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Diosdado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Berovides]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Universidad para todos: Historia y repercusión de un descubrimiento. La estructura espacial de la molécula de ADN]]></source>
<year>2003</year>
<page-range>32</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Academia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Negrín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Padrón]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<source><![CDATA[Universidad para Todos curso: Proyecto Genoma Humano]]></source>
<year>2005</year>
<page-range>32</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Academia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Negrín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Pujols]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Universidad para Todos: Biotecnología y adulto mayor]]></source>
<year>2008</year>
<page-range>32</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Academia]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
